#USA #Pleasanton #Novo Nordisk #CRM #Veeva Vault

Novo Nordisk Expands Partnership with Veeva Systems

On January 7, 2026, Veeva Systems, recognized on the NYSE under the ticker VEEV, announced that Novo Nordisk's international operations division has committed to utilizing Veeva Vault CRM. This advanced customer relationship management solution is designed to enhance the efficiency and productivity of sales teams across personalized and digital channels.

Peter Gassner, CEO of Veeva, expressed his enthusiasm about this collaboration, noting, "We are honored to expand our partnership with Novo Nordisk on Vault CRM. By leveraging AI-driven technology, we strive to support Novo Nordisk in delivering groundbreaking treatments for serious chronic diseases, ensuring long-term patient health worldwide."

The Role of Vault CRM

Veeva Vault CRM is a part of the broader Vault Suite, which includes specialized applications enhanced by agent-based AI. This comprehensive suite aims to streamline business operations and meet the unique, evolving compliance regulations of the pharmaceutical industry. Its advanced global capabilities are tailored to the specific needs of each market, enabling businesses to navigate the complexities of international healthcare.

Emil Kongshøj Larsen, the Executive Vice President of Novo Nordisk's international division, shared insights into the strategic importance of this decision: "We are excited to deepen our strategic partnership with Veeva by migrating to Vault CRM. This solution will help Novo Nordisk establish a solid technological foundation to support our commercial implementation efforts."

A Commitment to Innovation

Veeva is recognized for providing cloud solutions specifically aimed at the life sciences sector, combining software, data, and consulting services. With over 1,500 clients ranging from major biopharmaceutical companies to emerging biotech firms, Veeva emphasizes innovation, product excellence, and customer success. As a Public Benefit Corporation, Veeva is committed to aligning the interests of its stakeholders, which includes clients, employees, shareholders, and the industries it serves.

With the implementation of Vault CRM, Novo Nordisk aims to leverage innovative technology to not only enhance its operational capabilities but also to improve overall patient outcomes through better service delivery and treatment management.

For those interested in exploring more about Veeva Vault CRM and its AI-driven features, additional information can be found at veeva.com/CRM. Moreover, Veeva encourages connections via LinkedIn to stay updated on their latest advancements and partnerships.

A Forward-Looking Focus

The announcement also contains forward-looking statements concerning Veeva's products and the anticipated benefits stemming from their adoption. As always, actual results may vary significantly based on a multitude of factors, including market dynamics and operational challenges. Investors and stakeholders are advised to consult Veeva's filings with the SEC for potential risks that may influence financial performance.

In conclusion, Novo Nordisk's strategic commitment to Veeva Vault CRM marks a significant step forward in its operational goals, aiming for enhanced patient care and commercial excellence in a rapidly evolving landscape. As the partnership evolves, it represents a critical intersection of technology and healthcare innovation.